The impact of β-glucan on the therapeutic outcome of experimental Trichinella spiralis infection.

Autor: Elgendy DI; Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt., Othman AA; Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt. ahmed_ali44@hotmail.com., Eid MM; Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt., El-Kowrany SI; Medical Parasitology Department, Faculty of Medicine, Tanta University, Tanta, Egypt., Sallam FA; Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt., Mohamed DA; Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt., Zineldeen DH; Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.; College of Medicine, Sulaiman AlRajhi University, 51942, Albukairiyah, Saudi Arabia.
Jazyk: angličtina
Zdroj: Parasitology research [Parasitol Res] 2023 Dec; Vol. 122 (12), pp. 2807-2818. Date of Electronic Publication: 2023 Sep 22.
DOI: 10.1007/s00436-023-07964-7
Abstrakt: Trichinellosis is a cosmopolitan zoonosis that is caused mainly by Trichinella spiralis infection. The human disease ranges from mild to severe and fatality may occur. The treatment of trichinellosis still presents a challenge for physicians. Anti-inflammatory drugs are usually added to antiparasitic agents to alleviate untoward immuno-inflammatory responses and possible tissue damage but they are not without adverse effects. Thus, there is a need for the discovery of safe and effective compounds with anti-inflammatory properties. This study aimed to evaluate the activity of β-glucan during enteral and muscular phases of experimental T. spiralis infection as well as its therapeutic potential as an adjuvant to albendazole in treating trichinellosis. For this aim, mice were infected with T. spiralis and divided into the following groups: early and late β-glucan treatment, albendazole treatment, and combined treatment groups. Infected mice were subjected to assessment of parasite burden, immunological markers, and histopathological changes in the small intestines and muscles. Immunohistochemical evaluation of NF-κB expression in small intestinal and muscle tissues was carried out in order to investigate the mechanism of action of β-glucan. Interestingly, β-glucan potentiated the efficacy of albendazole as noted by the significant reduction of counts of muscle larvae. The inflammatory responses in the small intestine and skeletal muscles were mitigated with some characteristic qualitative changes. β-glucan also increased the expression of NF-κB in tissues which may account for some of its effects. In conclusion, β-glucan showed a multifaceted beneficial impact on the therapeutic outcome of Trichinella infection and can be regarded as a promising adjuvant in the treatment of trichinellosis.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: